Fusion Pharmaceuticals Q2 EPS $(0.63) Up From $(2.99) YoY

Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.63) per share. This is a 78.93 percent increase over losses of $(2.99) per share from the same period last year.

Fusion Pharmaceuticals (NASDAQ:FUSN) reported quarterly losses of $(0.63) per share. This is a 78.93 percent increase over losses of $(2.99) per share from the same period last year.

Total
0
Shares
Related Posts